Medicine Research news
A research group led by Dr. A. Claudio Cuello of McGill University’s Faculty of Medicine, Dept. of Pharmacology and Therapeutics, has uncovered a critical process in understanding the degeneration of brain cells sensitive to Alzheimer’s disease (AD). The study, published in the February issue of the Journal of Neuroscience, suggests that this discovery could help develop alternative AD therapies.
A new study conducted by researchers from McGill University, the Research Institute of the McGill University Health Centre (RI MUHC), and Sainte-Justine University Hospital Research Centre, has put the accuracy of rapid influenza diagnostic tests (RIDTs) under the microscope. The meta-analysis of 159 studies showed three key findings.
Could depression in adulthood be tied to a parent’s level of education? A new study led by Amélie Quesnel-Vallée, a medical sociologist from McGill University, suggests this is the case.
In a new paper published in the journal Cancer Prevention Research, researchers from McGill University and the University of Montreal reported on how the diabetes drug metformin potentially reduces cancer risk.
Tribal Nova and McGill develop interactive and participative reading method in conjunction with HarperCollins Publishers
Tribal Nova and the School of Communication Sciences and Disorders at McGill University have combined their expertise in a research and development project that focuses on interactive and participative reading on the iPad, in conjunction with HarperCollins Publishers.
Users of game designed by McGill researchers contributing to analysis of DNA sequences Thousands of video game players have helped advance our understanding of the genetic basis of diseases such as Alzheimer’s, over the past year. They are the users of a web-based video game developed by Dr. Jérôme Waldispuhl of McGill's School of Computer Science and collaborator Mathieu Blanchette.
New research out of McGill University’s Goodman Cancer Research Centre provides compelling new evidence that a gene known as 14-3-3σ plays a critical role in halting breast cancer initiation and progression. The study, led by the Dept. of Biochemistry’s William J. Muller, will be published online today in the journal Cancer Discovery.
A new potential target to slow breast cancer tumor progression and metastasis has been identified by a team of researchers led by Dr. Richard Kremer from the Research Institute of the McGill University Health Centre (RI-MUHC).